GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial shift in how we approach type 2 diabetes . These new drugs function to mimicking the body’s inherent GLP-1 substance , which https://thesocialdelight.com/story7368372/glp-1-a-major-advance-in-diabetes-care